The FGF-1-specific single-chain antibody scFv1C9 effectively inhibits breast cancer tumour growth and metastasis

Immunotherapy mediated by recombinant antibodies is an effective therapeutic strategy for a variety of cancers. In a previous study, we demonstrated that the fibroblast growth factor 1 (FGF-1)-specific recombinant antibody scFv1C9 arrests the cell cycle at the G0/G1 transition by blocking the intrac...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Hengliang, Fu, Chunling, Wang, Wei, Li, Yu, Du, Shuang, Cao, Rangjuan, Chen, Jingying, Sun, Dong, Zhang, Zhongyu, Wang, Xingzhi, Zhu, Xiaojuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244020/
https://www.ncbi.nlm.nih.gov/pubmed/25124967
http://dx.doi.org/10.1111/jcmm.12371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244020/
https://www.ncbi.nlm.nih.gov/pubmed/25124967
http://dx.doi.org/10.1111/jcmm.12371

Ejemplares similares